Evidence map›Paper›PMID 36866276›Full record

ArticleFrontiers in cell and developmental biology2023

A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS.

Bita Massih, Alexander Veh, Maren Schenke, Simon Mungwa, Bettina Seeger, Bhuvaneish T Selvaraj, Siddharthan Chandran, Peter Reinhardt, Jared Sterneckert, Andreas Hermann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Recent Advances in Transparent Electrodes and Their Multimodal Sensing Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Bita MassihInstitute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Alexander VehInstitute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Maren SchenkeInstitute for Food Quality and Safety, Research Group Food Toxicology and Alternative/Complementary Methods to Animal Experiments, University of Veterinary Medicine Hannover, Hannover, Germany.
Simon MungwaInstitute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Bettina SeegerInstitute for Food Quality and Safety, Research Group Food Toxicology and Alternative/Complementary Methods to Animal Experiments, University of Veterinary Medicine Hannover, Hannover, Germany.
Bhuvaneish T SelvarajCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Siddharthan ChandranCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Peter ReinhardtCenter for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
Jared SterneckertCenter for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
Andreas HermannTranslational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, Rostock, Germany.
Michael SendtnerInstitute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Patrick LüningschrörInstitute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Universitätsklinikum Würzburg · DETU Dresden · DEUniversity of Veterinary Medicine Hannover, Foundation · DEUK Dementia Research Institute · GBUniversity of Edinburgh · GBUniversity of Rostock · DE

Funding

Medical Research Council MR/N013255/1
6 · The paper itself

Abstract

The signals that coordinate and control movement in vertebrates are transmitted from motoneurons (MNs) to their target muscle cells at neuromuscular junctions (NMJs). Human NMJs display unique structural and physiological features, which make them vulnerable to pathological processes. NMJs are an early target in the pathology of motoneuron diseases (MND). Synaptic dysfunction and synapse elimination precede MN loss suggesting that the NMJ is the starting point of the pathophysiological cascade leading to MN death. Therefore, the study of human MNs in health and disease requires cell culture systems that enable the connection to their target muscle cells for NMJ formation. Here, we present a human neuromuscular co-culture system consisting of induced pluripotent stem cell (iPSC)-derived MNs and 3D skeletal muscle tissue derived from myoblasts. We used self-microfabricated silicone dishes combined with Velcro hooks to support the formation of 3D muscle tissue in a defined extracellular matrix, which enhances NMJ function and maturity. Using a combination of immunohistochemistry, calcium imaging, and pharmacological stimulations, we characterized and confirmed the function of the 3D muscle tissue and the 3D neuromuscular co-cultures. Finally, we applied this system as an

Indexed as

3D cell cultureiPSC (induced pluripotent stem cells)motoneuron (MN)NMJ–neuromuscular junctionskeletal muscle

Identifiers

PMID36866276
PMCPMC9973451
OpenAlexW4320724998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.